IHC - P
mouse tumor tissue (from lung) with human cell line injected, some muscle tissue attached as well sees high background for human cellswith priamry Ab as well as isotype ctrl, but also for muscle (does not contain any EGF) Ab: 1 ug /...
Not exact matches
PDX models are created by implanting cancerous
tissue from a human primary
tumor directly into immunodeficient
mouse or rat models, enabling acceleration of oncology research or drug discovery and development programs.
Researchers used
tissue and blood samples to show that the gammopathy (a precursor to myeloma) in both
mice and patients with Gaucher disease is triggered by specific lipids, and that the antibodies made by
tumor cells in nearly a third of myeloma patients are directed against such lipids.
The results indicate that while Tregs in the
tumors of Helios - lacking
mice underwent conversion, Tregs in the rest of the animals»
tissues remained stable.
The stem - cell - derived bone
tissue helped repair cranial bone defects in
mice without developing
tumors or causing infection.
However, cancer cells may instead be coaxed to turn back into normal
tissue simply by reactivating a single gene, according to a study that found that restoring normal levels of a human colorectal cancer gene in
mice stopped
tumor growth and re-established normal intestinal function within only 4 days.
To overcome these problems, Min and his team developed a new modality to visualize glucose uptake activity inside single cells based on stimulated Raman scattering (SRS) imaging, and demonstrated its use in live cancer cells,
tumor xenograft
tissues, primary neurons and
mouse brain
tissues.
This technique is able to distinguish cancer cell lines with differing metabolic activities and reveals heterogeneous uptake patterns in neurons,
mouse brain
tissues and
tumor tissues with clear cell - to - cell variations.
Patient - derived xenographs involve the implantation of
tumor tissue into an immunodeficient
mouse which becomes an avatar to help identify which drug or drug combinations are most likely to be effective for an individual cancer patient.
In 2001 Jeffrey W. Pollard and his co-workers at the Albert Einstein College of Medicine described
mice that were genetically engineered to be susceptible to breast cancer
tumors but that produced precancerous
tissue that did not turn fully malignant unless it enlisted the assistance of macrophages.
In this latest study, researchers were able to demonstrate the ability of the nanosensor to illuminate
tumor tissue in multiple
mouse models.
To test this idea, the researchers utilized two
mouse models of human breast cancer metastasis and found dormant disseminated
tumor cells residing upon the membrane microvasculature of lung, bone marrow and brain
tissue.
Human
tumor tissue or cell lines can be coengrafted into these
mouse models, providing a powerful tool for studying the interactions between human immune cells and human cancers.
Both the number and activity of osteoblasts — cells that produce and reshape bone
tissue — were increased within the bone marrow of
mice with lung
tumors compared with cancer - free animals; and reducing the number of osteoblasts in
mice not only limited neutrophil infiltration of
tumors but also interrupted
tumor progression.
In their research, scientists at Rutgers created animal models that closely resemble the cancerous
tumors found in women with ovarian cancer by injecting
tumor tissues obtained from gynecological cancer patients treated at the Cancer Institute into laboratory
mice.
«Our work outlines the genetic similarities of the
tissue and cells in different types of
tumors and shows the strong relationships
mice can have to other human cancers too.»
Lymphomas are cancers of immune cells that may have arisen from lymphatic
tissue present in the breast
tumors transplanted into the
mice.
She also collected visceral fat
tissue from women undergoing hysterectomies and found that when the fat secretions had more of the FGF2 protein, more of the cells formed cancerous
tumors when transferred into
mice.
When antibodies and other methods were used to dramatically deplete the supply of Tregs in
mice, the researchers saw a dramatic jump in the numbers of activated dendritic cells and CD8 + T cells in pancreatic
tumor tissue, as well as a slowing of
tumor growth.
This repair, which was tested in
mice and
tissue cultures, slowed cancerous
tumor growth.
In their search for novel,
tumor - specific therapies that could target multiple brain metastases without damaging adjacent
tissues, the research team first developed a
mouse model that more closely mimics what is seen in patients.
Next steps include He's collaboration with Piedmont Atlanta Hospital to retrieve T cells, liver cancer cells and healthy
tissue normally removed from patients during surgery, put the
mouse receptor genes on these T cells and monitor in a dish both how those cells now fight the
tumor and react to healthy human
tissue.
To further validate our result in clinical samples, we obtained primary
tumor from patients with advanced breast cancer and the
tissue was passaged once in nonobese diabetic / severe combined immunodeficient
mouse without in vitro culture.
Additionally, organizations such as Freiburg - based Oncotest, a company founded and directed by Fiebig, and the Jackson Laboratory in Bar Harbor, Maine, provide access to a wide range of PDX
mice made from donated
tumor tissue.
Gold nanotubes engineered to a specified length, modified surfaces, and to have other desirable characteristics showed expected abilities to enter
tumor cells in laboratory studies, and to distribute to
tissues within live
mice as intended.
We are using
mouse models in conjunction with human
tissue analysis to understand how this fibrosis arises and how it can be altered to allow access of chemotherapeutic agents to the
tumor.
The new iPS cells passed the standard tests for pluripotency: They formed
tumors called teratomas when injected into immunocompromised
mice, and they could differentiate into cells from the three main
tissue types in the body, including neurons, muscle and gut epithelium.
The researchers took healthy
tissue and
tumor samples from
mice, and trained the nanoparticle - GFP sensors to recognize the bad cells, and for the GFP to fluoresce in the presence of metastatic
tissues.
Tumors from nonautolyzed
tissues were recovered from moribund or recently deceased
mice.
To evaluate
tumor growth in
mice of each genotype, we used an orthotopic implant model derived from a spontaneous pancreatic
tumor arising in a C57BL / 6 KPC
mouse (33), which expresses mutant forms of K - Ras and p53 selectively in pancreatic
tissue.
An account of the discovery that
tumors in
mice metabolize glucose and glutamine differently depending on whether they are induced by the Myc or Met oncogene and on which
tissue the
tumors arise in.
Bottom Line: Bacterial load was significantly higher in pancreatic
tumor samples from patients with pancreatic ductal adenocarcinoma compared with pancreatic
tissue from normal individuals, and in studies using
mice, eliminating certain «bad» bacteria slowed the growth of pancreatic cancer, reversed immune suppression, and upregulated the immune checkpoint protein PD1.
Studying cells from the stomach and pancreas in humans and
mice, as well as
mouse kidney and liver cells, and cells from more than 800
tumor and precancerous lesions in people, the researchers found when
tissue is injured by infections or trauma, mature cells can revert back to a stem - cell state in which they divide repeatedly.
In addition to her expertise in
tumor biology and a broad network of connections with leading scientists and clinicians in cancer research and clinical oncology, Dr. Almog has extensive hands - on experience with a variety of techniques ranging from the molecular level (DNA, RNA and proteins) to
tissue, organ and
mouse models in cancer biology, as well as extensive experience in project management and program coordination.
Humanized
mouse models, where human
tumor tissue is engrafted into immunodeficient NOD SCID gamma (NSG)
mice, are frequently used in oncology and infectious disease studies to provide valuable translational insights.
What they found: Denosumab delayed and prevented
tumor growth in the
tissue samples and the
mice.